GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human cytochrome P4503A4 bound to an inhibitor ritonavir

Analyse Crystal structure of human cytochrome P4503A4 bound to an inhibitor ritonavir in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3NXU
Type
protein
Length
914 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytochrome P450 3A4
EC
1.14.13.67, 1.14.13.97, 1.14.13.32
UniProt
P08684
Ligands
HEM, RIT
Pockets
12 · best druggability 0.86

Structure

x-ray diffraction · 1 distinct chain · 54% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCytochrome P450 3A4 (EC 1.14.13.67, 1.14.13.97, 1.14.13.32)protein45754% helix, 9% strandP08684

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · 2 copies · chains A, B
  • RIT · Ritonavir · ligand · 2 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111410.860.8674HEM, RIT
211560.850.8573HEM, RIT
39640.740.7768empty
46190.730.8034empty
51320.550.8227empty

Interfaces

1 interface between chains.

  • A–B · 371 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 3NXU · Crystal structure of human cytochrome P4503A4 bound to an inhibitor ritonavir · the same entry in another collection · chain A against A, TM-score 1.00
  • P08684 · AlphaFold monomer V2.0 prediction for cytochrome P450 3A4 (P08684) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.